| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/23/2010 | US7666995 Interferons, uses and compositions related thereto |
| 02/23/2010 | US7666904 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666863 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases |
| 02/23/2010 | US7666848 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 02/23/2010 | US7666830 Nutritional composition preventing bacterial overgrowth |
| 02/23/2010 | US7666639 Plant deoxyribonucleoside kinase enzymes and their use |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666624 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/23/2010 | US7666581 Complexing antigenic proteins/peptides; membrane proteins; tumor associated antigens |
| 02/23/2010 | US7666440 Dermatomycosis vaccine |
| 02/23/2010 | US7666439 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 02/23/2010 | US7666434 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 02/23/2010 | US7666426 Method for immune response eliciting in a mammal |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | US7666398 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
| 02/23/2010 | CA2470492C Aqueous compositions containing metronidazole |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/23/2010 | CA2315277C Pharmaceutical compositions containing the long pentraxin ptx3 |
| 02/23/2010 | CA2138933C Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases |
| 02/18/2010 | WO2010019777A1 Local anti-infective agent for treatment of nail fungal infections |
| 02/18/2010 | WO2010019698A2 Inhibition of calicivirus (norovirus) |
| 02/18/2010 | WO2010019611A2 Bridged polycyclic compound based compositions for topical and oral applications |
| 02/18/2010 | WO2010019511A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 02/18/2010 | WO2010019489A2 Method for making terpene derivatives |
| 02/18/2010 | WO2010018847A1 Recombinant protein-s composition |
| 02/18/2010 | WO2010018474A2 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof |
| 02/18/2010 | WO2010018371A2 Antimicrobial agent and method for the production thereof |
| 02/18/2010 | WO2010018233A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 02/18/2010 | WO2010017633A1 Use of nitric oxide |
| 02/18/2010 | WO2010017623A1 Antimicrobial silver solutions |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009144738A4 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 02/18/2010 | WO2009083521A3 Antibacterial compositions comprising an antiseptic in combination with an antibiotic |
| 02/18/2010 | WO2009080432A3 Composition for treatment of tuberculosis |
| 02/18/2010 | US20100041868 Conserved neisserial antigens |
| 02/18/2010 | US20100041766 Medthods, Devices And Formulations For Targeted Endobronchial Therapy |
| 02/18/2010 | US20100041753 Inhibition of biofilm formation |
| 02/18/2010 | US20100041747 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 02/18/2010 | US20100041745 Aigialomycin D and Derivatives Thereof and Their Use in Treating Cancer or Malaria or a Microbial Infection |
| 02/18/2010 | US20100041734 Modulation of toll-like receptor 7 expression by antisense oligonucleotides |
| 02/18/2010 | US20100041733 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 02/18/2010 | US20100041732 Methods for identifying compounds that inhibit hiv infection |
| 02/18/2010 | US20100041728 Hcv inhibiting macrocyclic phenylcarbamates |
| 02/18/2010 | US20100041687 Hydrobromide salt of an anti-hiv compound |
| 02/18/2010 | US20100041658 Hydroxyphenyl Derivatives and Biological Applications Thereof |
| 02/18/2010 | US20100041649 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth |
| 02/18/2010 | US20100041648 Methods for treating retroviral infections |
| 02/18/2010 | US20100041631 Methods and agents for treating tuberculosis |
| 02/18/2010 | US20100041626 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas |
| 02/18/2010 | US20100041613 Novel antibiotic compositions |
| 02/18/2010 | US20100041591 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100041072 Process for identifying a ligand that binds to the nep binding site for the smr1 pentapeptide |
| 02/18/2010 | US20100040658 Antiviral composition and method of use |
| 02/18/2010 | US20100040656 Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them |
| 02/18/2010 | US20100040649 Inducible expression systems |
| 02/18/2010 | US20100040646 Split-Core-Particles for the Presentation of Foreign Molecules, Especially for Vaccine Applications, and Method for their Production |
| 02/18/2010 | US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent |
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040642 Novel peptide adjuvant for influenza vaccination |
| 02/18/2010 | US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists |
| 02/18/2010 | US20100040635 Neutralizing antibodies to influenza viruses |
| 02/18/2010 | US20100040614 Compositions and methods for the treatment of infections and tumors |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040606 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040602 Antibodies against Human Cytimegalovirus (HCMV) |
| 02/18/2010 | US20100040601 Compositions and methods for treating herpes simplex virus infections and related diseases |
| 02/18/2010 | US20100040589 Novel Compositions and Uses Thereof |
| 02/18/2010 | US20100040546 Biological targeting compositions and methods of using the same |
| 02/18/2010 | US20100040541 Structural Variants of Antibodies for Improved Therapeutic Characteristics |
| 02/18/2010 | CA2734335A1 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 02/18/2010 | CA2734191A1 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof |
| 02/18/2010 | CA2733762A1 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors |
| 02/18/2010 | CA2733642A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | CA2733553A1 Local anti-infective agent for treatment of nail fungal infections |
| 02/18/2010 | CA2733509A1 Antimicrobial silver solutions |
| 02/17/2010 | EP2154251A1 Expression system of recombinant proteins with enhanced yield and immunogenicity |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2154147A1 A truncated l1 protein of human papillomavirus 16 |
| 02/17/2010 | EP2154137A1 Crystalline form of moxifloxacin base |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153838A1 Anti-norovirus agent, and composition comprising the same |
| 02/17/2010 | EP2153832A2 Heterocyclic aspartyl protease inhibitors |
| 02/17/2010 | EP2152746A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 02/17/2010 | EP2152740A1 Products for altering il-33 activity and methods therefor |
| 02/17/2010 | EP2152736A1 Complement factor h-derived short consensus repeat-antibody constructs |
| 02/17/2010 | EP2152731A2 Klebsiella antigens |
| 02/17/2010 | EP2152701A1 Phenyl amino pyrimidine compounds and uses thereof |
| 02/17/2010 | EP2152261A1 Treatment of virally induced lesions |
| 02/17/2010 | EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer |
| 02/17/2010 | EP1565430B1 Biguanide derivatives |
| 02/17/2010 | EP1551839B1 Process for preparing 9-¬4-acetoxy-3-(acetoxymethyl)but-1-yl -2-aminopurine |
| 02/17/2010 | EP1549322B1 Lipid a and other carbohydrate ligand analogs |
| 02/17/2010 | EP1511737B1 Aryloximes |
| 02/17/2010 | EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof |